levodopa/carbidopa/entacapone orion
orion corporation - levodopa, carbidopa, entakapon - parkinsons sygdom - nervesystem - levodopa/carbidopa/entacapone orion er indiceret til behandling af voksne patienter med parkinsons sygdom og slutningen af dosis motor udsving ikke stabiliseret på levodopa / dopa-decarboxylase (ddc)-inhibitor behandling.
nebivolol "orion" 5 mg tabletter
orion corporation - nebivololhydrochlorid - tabletter - 5 mg
sildenafil "orion" 100 mg filmovertrukne tabletter
orion corporation - sildenafilcitrat - filmovertrukne tabletter - 100 mg
sildenafil "orion" 50 mg filmovertrukne tabletter
orion corporation - sildenafilcitrat - filmovertrukne tabletter - 50 mg
amlodipin "orion" 10 mg tabletter
orion corporation - amlodipinmaleat - tabletter - 10 mg
candesartan/hydrochlorothiazide "orion" 16+12,5 mg tabletter
orion corporation - candesartancilexetil, hydrochlorthiazid - tabletter - 16+12,5 mg
alfuzosin "orion" 10 mg depottabletter
orion corporation - alfuzosinhydrochlorid - depottabletter - 10 mg
alfuzosin "orion" 2,5 mg filmovertrukne tabletter
orion corporation - alfuzosinhydrochlorid - filmovertrukne tabletter - 2,5 mg
ipratropium/salbutamol "orion" 0,5+2,5 mg/beholder inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder
orion corporation - ipratropiumbromid, salbutamolsulfat - inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder - 0,5+2,5 mg/beholder
mometason "orion" 50 mikrogram/dosis næsespray, suspension
orion corporation - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis